Evidence map›Paper›PMID 41405765›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2025

Identification of a novel circular DNA carrying bla

Shaoyi Liu, Zhiming Gong, Xixi Wu, Jianfen Xu, Xiaolei Hu, Hui Ding, Xiuying Chen, Rongzhen Wu, Jiansheng Huang

Abstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shaoyi Liu *The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang, China.
Zhiming Gong *The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang, China.
Xixi WuThe Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang, China.
Jianfen XuThe Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang, China.
Xiaolei HuThe Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang, China.
Hui DingThe Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang, China.
Xiuying ChenLishui Center for Disease Control and Prevention, Lishui, Zhejiang, China.
Rongzhen WuThe Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang, China.
Jiansheng HuangThe Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang, China. Huangxvy@163.com.ORCID http://orcid.org/0000-0002-0545-1543

Funding

Lishui Science and Technology Bureau 2024SJZC094the Major Research and Development Project of Lishui City 2023ZDYF16the Natural Science Foundation of Zhejiang Province LHDMY24H190001the Natural Science Foundation of Zhejiang Province LHDMZ23H190001
6 · The paper itself

Abstract

Providencia, as an opportunistic pathogen, can cause serious infections and increasingly poses a life-threatening risk to public health. Carbapenems were initially considered effective agents conquering such infectious; however, the emergence of carbapenem-resistant Providencia strains has been attributed to the rapid spread of carbapenemase genes. In this study, we first reported a uniquely bla

Indexed as

Anti-Bacterial Agentsbeta-LactamasesDNA, CircularDrug Resistance, Multiple, BacterialProvidenciaBacterial ProteinsCarbapenemsDNA, BacterialEnterobacteriaceae InfectionsHumansMicrobial Sensitivity TestsPlasmidsWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase NDM-1beta-LactamasesCarbapenemsDNA, BacterialDNA, Circularbla NDM−1 genetic structureCarbapenem resistanceCircular DNAProvidencia huaxiensis

Identifiers

PMID41405765
PMCPMC12712267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.